LV
LVVV.US Livewire Ergogenics
- Market cap
- USD 571K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is LVVV.US undervalued?
Graham numberThe Graham number of Livewire Ergogenics cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Livewire Ergogenics fundamental analysis
No fundamental analysis for Livewire Ergogenics yet.
Livewire Ergogenics stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Livewire Ergogenics
LiveWire Ergogenics, Inc., engages in the development and marketing of handcrafted cannabis-based and hemp-derived products for medical and recreational use in the United States. The company is also involved in developing and licensing cannabinoid-based specialty products and services under the SOL VIDA Wellness and Estrella Weedery brand names. LiveWire Ergogenics, Inc. is based in Anaheim, California.
Full company profileLivewire Ergogenics financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Livewire Ergogenics annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 9.07K | 20.4K | 35.7K | 344K | 580K | 851K | 1.94M | 1.63M | 304K | 7.84K | 104K |
| Gross Profit | 1.07K | 11.9K | -142K | 197K | 377K | 702K | 1.81M | 1.59M | 285K | -17.4K | 55.6K |
| Operating Income | -18.8K | -768K | -8.07M | -1.04M | -465K | -2.49M | 645K | 830K | 119K | -182K | -58.4K |
| EBITDA | -17.5K | 42.3K | -10.7M | -515K | -302K | -2.68M | 1.07M | 1.22M | 322K | -157K | -33.1K |
| Net Income | -78.3K | -1.20M | -11.6M | -1.78M | -1.60M | -3.43M | 684K | 922K | 78.7K | -4.78M | -1.43M |
| EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 146K | 113K | 1.75M | 3.32M | 2.91M | 4.52M | 6.27M | 7.74M | 7.96M | 2.26M | 2.24M |
| Total Liabilities | 1.08M | 1.13M | 1.95M | 3.10M | 3.99M | 3.61M | 4.24M | 4.62M | 4.70M | 3.78M | 4.46M |
| Shareholders' Equity | -934K | -1.02M | -194K | 374K | -1.08M | 912K | 2.03M | 3.11M | 3.24M | -1.51M | -2.23M |
| Cash & Short-term Investments | 23.5K | 113K | 27.9K | 53.7K | 110K | 200K | 76.4K | 27.9K | 11.3K | 1.48K | 7.81K |
| Total Debt | 684K | 736K | 1.37M | 2.43M | 3.23M | 2.85M | 3.20M | 3.34M | 3.35M | 3.05M | 3.78M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -676.00 | -175K | -862K | -779K | 356K | -400K | 396K | 682K | 125K | -7.31K | 12.6K |
| Capital Expenditure | 0.00 | 385K | 485K | 11.2K | 40.8K | 67.3K | 0.00 | 0.00 | 0.00 | 1.00 | 12.00 |
| Free Cash Flow | -676.00 | -175K | -1.35M | -790K | 315K | -467K | 396K | 682K | 125K | -7.31K | 12.6K |
| Ratios | |||||||||||
| ROE | - | - | - | -474.9% | - | -376.3% | 33.7% | 29.6% | 2.4% | - | - |
| ROA | -53.6% | -1,062.0% | -661.7% | -53.4% | -55.0% | -75.9% | 10.9% | 11.9% | 1.0% | -211.5% | -64.1% |
| Net Profit Margin | -863.0% | -5,871.4% | -32,465.2% | -515.9% | -275.9% | -403.2% | 35.3% | 56.4% | 25.9% | -61,057.3% | -1,374.5% |
| Debt to Equity | - | - | - | 6.49x | - | 3.12x | 1.58x | 1.07x | 1.03x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Livewire Ergogenics dividends
Livewire Ergogenics has not paid dividends in the last 9 fiscal years.
Last stock split: 6:5 on Jan 16, 2013.
Who owns Livewire Ergogenics
Ownership data of Livewire Ergogenics is not available yet.
Livewire Ergogenics company profile
- Company name
- Livewire Ergogenics
- Ticker
- LVVV.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Personal Care Products
- Employees
- 1
- Fiscal year end
- December
- Address
- 1600 North Kraemer Boulevard, Anaheim, CA, United States, 92806
- Phone
- 714 740 5144
- Website
- livewireergogenics.com
About Livewire Ergogenics
LiveWire Ergogenics, Inc., engages in the development and marketing of handcrafted cannabis-based and hemp-derived products for medical and recreational use in the United States. The company is also involved in developing and licensing cannabinoid-based specialty products and services under the SOL VIDA Wellness and Estrella Weedery brand names. LiveWire Ergogenics, Inc. is based in Anaheim, California.
Livewire Ergogenics management
4- Mr. William J. HodsonCEO, Chief Accounting Officer, Treasurer & Director · born 1967
- Mr. William RileyPresident
- Mr. AJ MorenoCompliance Manager - Government Liaison
- Mr. Kyle McKayMaster Horticulturist, Member of Scientific Advisory Board and 7Xpure Advisory & Compliance Board